Safety and efficacy of nateglinide/metformin combination therapy in the treatment of type 2 diabetes
Marc K Israel1, Eva Istvan2, Michelle A Baron1,31Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA; 2Novartis AG, Basel, Switzerland; 3Sanofi-Aventis, Bridgewater, New Jersey, USAAbstract: The increasing prevalence of type 2 diabetes provides impetus for both development of new dru...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2008-12-01
|
| Series: | Vascular Health and Risk Management |
| Online Access: | https://www.dovepress.com/safety-and-efficacy-of-nateglinidemetformin-combination-therapy-in-the-peer-reviewed-article-VHRM |